ÂÜÀòÂÒÂ×

Ophelia Yin has a diverse work experience that spans over several years. Ophelia is currently the Vice President and Head of Clinical Pharmacology at iTeos Therapeutics, starting in May 2023. Prior to that, they were the Head of Pharmacometrics at Agios Pharmaceuticals from November 2020 to May 2023. Ophelia also worked at Daiichi Sankyo, Inc., where they held several positions including Executive Director and Head of Advanced Pharmacometrics from October 2016 to November 2020. Ophelia also served as a Senior Director and Director of Modeling and Simulation during their time at Daiichi Sankyo. Before joining Daiichi Sankyo, Ophelia worked at Novartis Oncology as a Senior Fellow and Senior Clinical Pharmacology Expert from March 2009 to July 2012, and as a Fellow and Clinical Pharmacology Expert from January 2007 to February 2009. Ophelia began their career at the Chinese University of Hong Kong, where they held positions as an Assistant Professor from September 2002 to October 2006, a Scientific Officer from October 2001 to September 2002, and a Postdoctoral Fellow from January 1999 to September 2001. Throughout their career, Ophelia has demonstrated expertise in clinical pharmacology and has contributed to various drug development teams and collaborations.

Ophelia Yin earned a Doctor of Philosophy (Ph.D.) in Pharmacology from Fudan University (formerly Shanghai Medical University) from 1995 to 1998.